Categorized | Journal Articles

Melanoma Journal Articles for March 2018

CANCER DISCOVERY

Research Watch

Patients with Desmoplastic Melanoma May Respond to PD-1 Blockade

DOI: 10.1158/2159-8290.CD-RW2018-012 Published March 2018


Dove Press

Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy

Authors Duan X, Mu M, Yan J, Bai L, Zhong L, Zhu Y, Pan H, Zhang M, Shi J

Received 30 July 2017

Accepted for publication 7 December 2017

Published 9 March 2018 Volume 2018:13 Pages 1443—1456

DOI https://doi.org/10.2147/IJN.S147759


American Chemical Society  Nano

Copper Silicate Hollow Microspheres-Incorporated Scaffolds for Chemo-Photothermal Therapy of Melanoma and Tissue Healing

Qingqing Yu†‡?Yiming Han§?Xiaocheng Wang†‡Chen Qin†‡Dong ZhaiZhengfang Yi*§Jiang Chang Yin Xiao?, and Chengtie Wu

DOI: 10.1021/acsnano.7b08928

Publication Date (Web): March 8, 2018


Neoadjuvant treatment for malignant and metastatic cutaneous melanoma.

Gorry C, McCullagh L, O’Donnell H, Barrett S, Schmitz S, Barry M, Curtin K, Beausang E, Barry R, Coyne I.

Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No.: CD012974. DOI: 10.1002/14651858.CD012974.


Sci Rep. 2018 Mar 7;8(1):4111. doi: 10.1038/s41598-018-22484-6.

Down-regulation of GADD45A enhances chemosensitivity in melanoma.

Liu J1Jiang G1Mao P2Zhang J1Zhang L3Liu L1Wang J1Owusu L4Ren B1Tang Y5Li W6.


The European Journal of Health Economics

The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England

Yang Meng, Nadine Hertel, John Ellis, Edith Morais, Helen Johnson, Zoe Philips, Neil Roskell, Andrew Walker, Dawn Lee

 

First Online: 09 March 2018

DOIhttps://doi.org/10.1007/s10198-018-0964-4


JNCI

Risk Stratification for Melanoma: Models Derived and Validated in a Purpose-Designed Prospective Cohort

Catherine M Olsen Nirmala Pandeya Bridie S Thompson Jean Claude DusingizePenelope M Webb Adele C Green Rachel E Neale David C Whiteman for the QSkin Study

JNCI: Journal of the National Cancer Institute,

https://doi.org/10.1093/jnci/djy023

Published: 11 March 2018


The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.

Sinnamon AJ, Sharon CE, Song Y, et al.

[Published online ahead of print March 5, 2018].

J Am Acad Dermatol. doi:10.1016/j.jaad.2018.02.066.


Cureus

Case report

Subungual Amelanotic Melanoma Masquerading as Onychomycosis

Ryan R. Riahi  Philip R. Cohen Leonard H. Goldberg

Published: March 11, 2018 (see history)

DOI: 10.7759/cureus.2307


Dove Press

Modulation of human melanoma cell proliferation and apoptosis by hydatid cyst fluid of Echinococcus granulosus

Authors Gao X, Zhang G, Huang L

Received 13 July 2017

Accepted for publication 31 October 2017

Published 15 March 2018 Volume 2018:11 Pages 1447—1456

DOI https://doi.org/10.2147/OTT.S146300


Journal of Interferon & Cytokine ResearchVol. 23, No. 10

Increased Interleukin-10 mRNA Stability in Melanoma Cells Is Associated with Decreased Levels of A + U-Rich Element Binding Factor AUF1

Gary Brewer, Simona Saccani, Srijata SarkarAnita LewisSidney Pestka

Published Online:7 Jul 2004

https://doi.org/10.1089/107999003322485053


Investigation and Stimulation of Immunity in Cancer Patients pp 476-485

BCG Stimulation of Immune Responsiveness in Patients with Malignant Melanoma

  1. U. Gutterman, G. Mavligit, Ch. M. McBride, E. FreiIII., E. M. Hersh

Conference paper

Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 47)


Dove Press

Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients

Authors Donizy P, Pagacz K, Marczuk J, Fendler W, Maciejczyk A, Halon A, Matkowski R

Received 9 September 2017

Accepted for publication 5 December 2017

Published 14 March 2018 Volume 2018:11 Pages 1413—1422

DOI https://doi.org/10.2147/OTT.S151286


Journal of Clinical Oncology

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)

Richard D. CarvajalSophie Piperno-NeumannEllen KapiteijnPaul B. ChapmanStephen FrankAnthony M. JoshuaJosep M. PiulatsPascal WolterVeronique CocquytBartosz ChmielowskiT.R. Jeffry EvansLauris GastaudGerald LinetteCarola BerkingJacob SchachterManuel J. RodriguesAlexander N. ShoushtariDelyth ClemettDana GhiorghiuGabriella MarianiShirley SprattSusan LovickPeter BarkerElaine KilgourZhongwu LaiGary K. Schwartz, and Paul Nathan

DOI: 10.1200/JCO.2017.74.1090 Journal of Clinical Oncology – published online before print March 12, 2018

PMID: 29528792


Oncology Letters

Targeted silencing of the ADP-ribosyltransferase 3 gene inhibits the migration ability of melanoma cells

Jie He, Yongyun Li, Ying Wang, He Zhang, Shengfang Ge, Xianqun Fan

Published online on: March 13, 2018     https://doi.org/10.3892/ol.2018.825


JAMA Dematology

Accuracy of Dermoscopic Criteria for the Diagnosis of Melanoma In Situ

Aimilios Lallas, PhD1Caterina Longo, PhD2Marco Manfredini, MD3; et alElisa Benati, MD2Graziella Babino, MD4Chiara Chinazzo, MD4Zoe Apalla, PhD1Chryssoula Papageorgiou, MD1Elvira Moscarella, MD4Athanassios Kyrgidis, PhD2Giuseppe Argenziano, PhD4

JAMA Dermatol. Published online February 21, 2018. doi:10.1001/jamadermatol.2017.6447


Oncology Times

The Reality of Precision Medicine in Metastatic Melanoma

Weber, Jeffrey S. MD, PhD

Oncology Times: March 20, 2018 – Volume 40 – Issue 6 – p 1–5

doi: 10.1097/01.COT.0000531929.16181.f4


Pigment Cell & Melanoma Research

The potent pro?oxidant activity of rhododendrol–eumelanin is enhanced by ultraviolet A radiation

Shosuke Ito, Misa Agata, Kotono Okochi, Kazumasa Wakamatsu

First published: 12 March 2018

https://doi.org/10.1111/pcmr.12696


Nature Medicine

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.

Boshuizen JKoopman LAKrijgsman OShahrabi Avan den Heuvel EGLigtenberg MAVredevoogd DWKemper KKuilman TSong JYPencheva NMortensen JTFoppen MGRozeman EABlank CU,Janmaat MLSatijn DBreij ECWPeeper DSParren PWHI

show author affiliations

Nat Med. 2018 Feb; 24(2):203-212


Cancer Research

Krüger-Krasagakes S., Krasagakis K., Garbe C., Diamantstein T. (1995) Production of Cytokines by Human Melanoma Cells and Melanocytes. In: Garbe C., Schmitz S., Orfanos C.E. (eds) Skin Cancer: Basic Science, Clinical Research and Treatment. Recent Results in Cancer Research, vol 139. Springer, Berlin, Heidelberg

DOIhttps://doi.org/10.1007/978-3-642-78771-3_11

Publisher Name Springer, Berlin, Heidelberg

Print ISBN978-3-642-78773-7

Online ISBN978-3-642-78771-3


Clinical Cancer Research

Cancer Therapy: Preclinical

Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma

Gao Zhang, Lawrence W Wu, ilgen Mender, Michal Barzily-Rokni, Marc R. Hammond, Omotayo Ope, Chaoran Cheng, Sergio Randell, Norah Sadek, Aurelie Beroard, Min Xiao, Tian Tian, Jiufeng Tan, Umar Saeed, Eric Sugarman, Clemens Krepler, Patricia A Brafford, Katrin Sproesser, Sengottuvelan Murugan, Rajasekharan Somasundaram, Bradley Garman, Bradley Wubbenhorst, Jonathan Woo, Xiangfan Yin, Qin Liu, Dennie T Frederick, Benchun Miao, Wei Xu, Giorgos C Karakousis, Xiaowei Xu, Lynn M. Schuchter, Tara C. Mitchell, Lawrence N. Kwong, Ravi K. Amaravadi, Yiling Lu, Genevieve Boland, Zhi Wei, Katherine L. Nathanson, Gordon B. Mills, Keith T. Flaherty, Jerry W Shay, Meenhard Herlyn, Themistoklis Vasilopoulos and Utz Herbig

DOI: 10.1158/1078-0432.CCR-17-2773


BOOK: Epidemiology of Malignant Melanoma

Tucker M.A., Hartge P., Shields J.A. (1986) Epidemiology of Intraocular Melanoma. In: Gallagher R.P. (eds) Epidemiology of Malignant Melanoma. Recent Results in Cancer Research, vol 102. Springer, Berlin, Heidelberg

DOIhttps://doi.org/10.1007/978-3-642-82641-2_14

Publisher Name Springer, Berlin, Heidelberg

Print ISBN978-3-642-82643-6

Online ISBN978-3-642-82641-2


Rechallenge With Nivolumab After Vemurafenib Treatment of Initially Nivolumab-Resistant Advanced Melanoma

Junji Kato, MD1Tokimasa Hida, MD, PhD1Takafumi Kamiya, MD, PhD1; et alSayuri Sato, MD1Hitomi Takahashi, MD1Toshihiko Torigoe, MD, PhD2Hisashi Uhara, MD, PhD1

JAMA Dermatol. Published online March 28, 2018. doi:10.1001/jamadermatol.2017.6400


JNCI: Journal of the National Cancer Institute,

Melanoma Screening and Mortality 

David E Elder

djy056,https://doi.org/10.1093/jnci/djy056

Published: 29 March 2018


PD-L1–Independent Mechanisms Control the Resistance of Melanoma to CD4+ T Cell Adoptive Immunotherapy

Stephen R. Goding, Kyle A. Wilson, Carolyn Rosinsky and Paul Andrew Antony

J Immunol March 30, 2018, ji1701617; DOI: https://doi.org/10.4049/jimmunol.1701617


Oncology Reports

Critical role for nonGAP function of G?s in RGS1mediated promotion of melanoma progression through AKT and ERK phosphorylation

MengYan Sun, Yuchong Wang, Ji Zhu, Chuan Lv, Kai Wu, XinWei Wang, ChunYu Xue

Published online on: March 30, 2018     https://doi.org/10.3892/or.2018.6341


 

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories